Top Markets
Coin of the day
Qlife Holding AB (publ) Qlife Holding AB (publ)

Qlife Holding AB (publ)

QLIFE
Peringkat dalam Saham #36577
Operating as a medical technology firm, Qlife Holding AB (publ) specializes in... Operating as a medical technology firm, Qlife Holding AB (publ) specializes in the production and distribution of in-vitro diagnostic instruments and their associated chemical reagents. Their flagship offering is the Egoo.Health Platform, a comprehensive system comprising a measuring device, single-use test capsules, and integrated software. This innovative platform facilitates the detection of various biomarkers or viral agents, with each capsule tailored for a distinct diagnostic purpose. The range of supported biomarkers encompasses C-reactive protein for home-based monitoring, Phenylalanine (PHE) vital for managing Phenylketonuria (PKU) in patients, and a multiplex test designed to identify Sars-CoV-2 and Influenza, aiding in the detection of viral and bacterial infections. Established in 2019, Qlife's operations are headquartered in Helsingborg, Sweden.
Harga Saham
$0.20529272
Terakhir disinkronkan: 2026-08-14
Kapitalisasi Pasar
$2.54M
Perubahan (1 hari)
0.11%
Perubahan (1 tahun)
-49.29%
Negara
SE
Perdagangan Qlife Holding AB (publ) (QLIFE)

Kategori

Rasio P/B untuk Qlife Holding AB (publ) (QLIFE)
Rasio P/B per 2026 TTM: 0
Menurut laporan keuangan dan harga saham terbaru dari Qlife Holding AB (publ), rasio P/B saat ini (TTM) adalah 0. Pada akhir 2026, rasio P/B perusahaan adalah 0.
Riwayat rasio P/B untuk Qlife Holding AB (publ) dari 2026 hingga 2026
Rasio P/B pada akhir setiap tahun
Tahun Rasio P/B Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Rasio P/B untuk perusahaan sejenis atau pesaing
Perusahaan Rasio P/B Perbedaan Rasio P/B Negara
3.7944 -
US
5.423 -
US
2.0146 -
IE
3.072 -
US
4.9725 -
US